4-aminoquinoline has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldhumani, AH; Boesger, H; Herath, D; Hines, JV; Hossain, MI; Myers, M | 1 |
| Svensson, M | 1 |
| Antunes, MM; Bazotte, RB; Cruzat, V; Curi, R; Gorjao, R; Gritte, RB; Hirabara, SM; Masi, LN; Pithon-Curi, TC; Serdan, TAD; Souza-Siqueira, T | 1 |
1 review(s) available for 4-aminoquinoline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
4-Aminoquinoline compounds from the Spanish flu to COVID-19.
Topics: Aminoquinolines; Antimalarials; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Influenza Pandemic, 1918-1919; SARS-CoV-2; Virus Replication | 2021 |
2 other study(ies) available for 4-aminoquinoline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
4-Aminoquinolines modulate RNA structure and function: Pharmacophore implications of a conformationally restricted polyamine.
Topics: Aminoquinolines; COVID-19; Humans; Hydroxychloroquine; Nucleic Acid Conformation; Pharmacophore; Polyamines; Riboswitch; RNA, Bacterial; RNA, Viral; SARS-CoV-2 | 2023 |
[Potential harms associated with 4-aminoquinoline treatment].
Topics: Aminoquinolines; Antimalarials; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |